Nike
NKE
$41.05
-1.04%
Nike, Inc. is the world's largest athletic footwear and apparel brand, operating in the consumer cyclical sector with a core business spanning performance and lifestyle products under the Nike, Jordan, and Converse brands. The company is a dominant market leader with a global distribution network of owned stores, franchisees, and third-party retailers, distinguished by its powerful brand equity, extensive outsourcing model, and direct-to-consumer strategy. The current investor narrative is intensely focused on a protracted turnaround story, as recent headlines and financial trends highlight persistent sales challenges, margin pressures, and skepticism over whether new leadership and strategic initiatives can reignite growth and justify the stock's valuation, which has suffered a significant decline.…
NKE
Nike
$41.05
Related headlines
Investment Opinion: Should I buy NKE Today?
Rating: Hold. The core thesis is that Nike is a high-quality brand in a painful transition, where the significant downside appears priced in but the catalyst for a sustained recovery remains elusive, making the risk/reward balanced at current levels.
Supporting evidence includes a forward P/E of 22.61x, which is elevated for a company with stagnant 0.09% revenue growth, yet represents a discount to its own historical trailing P/E of 27.92x. The company's strong financial metrics—ROE of 24.36%, current ratio of 2.21, and $2.48B in TTM FCF—provide a margin of safety. However, the sharp -34.84% one-year price decline and persistent margin pressure (gross margin down to 40.16%) validate the market's skepticism.
The thesis would upgrade to Buy if the forward P/E compresses further toward 18x without a deterioration in fundamentals, or if the company demonstrates a clear inflection in revenue growth (back above 5% YoY) and gross margin stabilization above 41%. It would downgrade to Sell if revenue turns negative YoY, the dividend yield becomes unsustainable due to falling FCF, or the stock breaks decisively below the $40 support level. Currently, the stock is fairly valued relative to its challenged near-term prospects but remains overvalued relative to its current growth trajectory.
Sign up to view all
NKE 12-Month Price Forecast
The outlook is clouded by a lack of near-term catalysts to reverse the negative momentum in fundamentals. The strong balance sheet and brand equity provide a floor, but the premium forward P/E of 22.6x is unjustified without visible top-line reacceleration. The base case of a protracted, messy turnaround is most probable. The stance would upgrade to bullish on evidence of sustainable gross margin expansion above 41% or quarterly revenue growth exceeding 5%. It would turn bearish on a breakdown below $40 support or a dividend cut announcement.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nike's 12-month outlook, with a consensus price target around $53.36 and implied upside of +30.0% versus the current price.
Average Target
$53.36
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$33 - $53
Analyst target range
Analyst coverage appears limited in the provided dataset, with only 3 analysts cited for estimates, suggesting insufficient coverage to form a robust consensus view; this limited coverage can contribute to higher volatility and less efficient price discovery for a company of Nike's size. The provided data shows an average estimated EPS of $4.25 for an unspecified period, but without a consensus price target or Buy/Hold/Sell distribution, the implied upside or downside cannot be calculated, and the sentiment signal is unclear; recent institutional ratings from firms like Barclays (upgrade to Overweight) and Needham (downgrade to Hold) indicate mixed and evolving opinions on the turnaround prospects.
Bulls vs Bears: NKE Investment Factors
The bear case currently holds stronger evidence, anchored by concrete deterioration in revenue growth (0.09% YoY) and profitability (34% sequential net income drop), which has driven a 35% stock decline over the past year. The bull case rests on a strong financial foundation (2.21 current ratio, $2.48B FCF) and the potential for a successful turnaround under new leadership, but these are defensive qualities rather than growth catalysts. The single most important tension in the investment debate is whether Nike's powerful brand equity and operational scale can overcome the current demand softness and margin pressures to justify its still-premium forward P/E of 22.6x, or if this marks a structural deceleration requiring a further valuation reset.
Bullish
- Strong Financial Foundation: Nike maintains a robust balance sheet with a current ratio of 2.21 and a manageable debt-to-equity ratio of 0.83, providing significant liquidity and flexibility. The company also generates substantial cash, with TTM free cash flow of $2.48 billion, funding its dividend and strategic initiatives.
- High Return on Equity: The company's return on equity of 24.36% is exceptionally strong, indicating efficient use of shareholder capital. This high ROE, combined with a solid net margin of 6.95%, demonstrates the underlying profitability of its brand and business model.
- Valuation Compression from Highs: The stock's trailing P/E of 27.92x represents a significant compression from its historical high of 44.21x, suggesting much of the growth premium has been eliminated. The forward P/E of 22.61x implies the market expects earnings recovery, offering a lower entry point for a turnaround.
- Attractive Dividend Yield: With a dividend yield of 2.56% and a payout ratio of 71.5%, Nike offers income stability during its growth transition. The strong cash flow generation supports this dividend, providing a tangible return while investors await operational improvement.
Bearish
- Severe Revenue Growth Stagnation: Revenue growth has effectively stalled, with Q3 FY2026 year-over-year growth of just 0.09% and a sequential decline from $12.43B to $11.28B. This deceleration signals fundamental softness in demand and challenges in reigniting top-line expansion.
- Sharp Profitability Erosion: Profitability is under severe pressure, with net income dropping 34% sequentially from $792M to $520M in the latest quarter. Gross margin compressed to 40.16% from 40.60%, reflecting promotional activity and cost inflation that are eroding earnings power.
- Sustained Technical Downtrend: The stock is in a pronounced downtrend, down 34.84% over the past year and trading at just 50.8% of its 52-week range ($40.0 to $80.17). It has severely underperformed the S&P 500 by 53.98% over one year, indicating deep company-specific weakness.
- Elevated Valuation Despite Weakness: Despite the steep decline, Nike's forward P/E of 22.61x and Price/Sales of 1.94x still command a premium valuation that demands a growth reacceleration to be justified. This creates valuation risk if the turnaround takes longer than expected.
NKE Technical Analysis
The stock is in a pronounced and sustained downtrend, evidenced by a 1-year price change of -34.84% and a current price of $40.75, which sits at just 50.8% of its 52-week range ($40.0 to $80.17), positioning it near multi-year lows and signaling deep investor pessimism rather than a clear value opportunity. Recent momentum remains sharply negative and aligned with the longer-term downtrend, with the stock down 11.37% over the past month and 20.67% over the past three months, severely underperforming the S&P 500 which gained 14.97% over three months, indicating significant company-specific weakness. Key technical levels are clearly defined, with immediate support at the 52-week low of $40.0 and resistance far above at the 52-week high of $80.17; a breakdown below $40.0 would signal a potential acceleration of the downtrend, while the stock's beta of 1.116 suggests it is moderately more volatile than the broader market, which is relevant for risk assessment during this period of elevated uncertainty.
Beta
1.12
1.12x market volatility
Max Drawdown
-48.6%
Largest decline past year
52-Week Range
$40-$80
Price range past year
Annual Return
-42.2%
Cumulative gain past year
| Period | NKE Return | S&P 500 |
|---|---|---|
| 1m | -11.2% | -1.3% |
| 3m | -8.0% | +14.0% |
| 6m | -35.6% | +9.5% |
| 1y | -42.2% | +20.9% |
| ytd | -35.1% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NKE Fundamental Analysis
Revenue growth has stalled and turned negative on a sequential basis, with the most recent Q3 FY2026 revenue of $11.28 billion representing a mere 0.09% year-over-year increase and a significant decline from the $12.43 billion reported in Q2, indicating deceleration and fundamental softness. Profitability is under severe pressure, as evidenced by a sharp sequential drop in net income from $792 million in Q2 to $520 million in Q3, with gross margin compressing to 40.16% from 40.60% in the prior quarter, reflecting promotional activity and cost challenges that are eroding earnings power. The balance sheet remains solid with a strong current ratio of 2.21 and a manageable debt-to-equity ratio of 0.83, while trailing twelve-month free cash flow of $2.48 billion and a return on equity of 24.36% indicate the company still generates substantial cash and returns on capital, providing a financial cushion to navigate the current downturn.
Quarterly Revenue
$11.3B
2026-02
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.40%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NKE Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 27.92x, while the forward P/E is 22.61x; the forward multiple's discount to the trailing figure implies the market expects some earnings recovery, but the absolute levels remain elevated for a company with stagnant growth. Compared to sector averages, Nike's trailing P/E of 27.92x and Price/Sales ratio of 1.94x are not directly comparable without provided industry benchmarks, but the forward P/E of 22.61x suggests a premium valuation that demands a growth reacceleration to be justified. Historically, the current trailing P/E of 27.92x is below the stock's own historical highs seen in recent years (e.g., 44.21x in Q3 FY2026 per historical data), indicating multiple compression has already occurred, but it remains above the lows seen during stronger profit periods, suggesting the market may still be pricing in a turnaround that has yet to materialize.
PE
21.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 24x~106x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on deteriorating fundamentals. Revenue growth has stalled at 0.09% YoY, while profitability is collapsing with a 34% sequential drop in net income and gross margin compression to 40.16%. The company faces significant execution risk in its turnaround strategy, with earnings volatility evident in the sharp decline from Q2's $792M net income to Q3's $520M. While the balance sheet is strong, continued weak performance could pressure cash flow generation and the 71.5% dividend payout ratio.
Market & Competitive Risks are elevated. Nike trades at a forward P/E of 22.61x, a premium valuation that demands growth reacceleration amid intense competition from both traditional rivals and newer entrants like Lululemon and Deckers' Hoka. The stock's beta of 1.116 indicates moderate market sensitivity, but its 53.98% underperformance versus the S&P 500 over one year highlights severe company-specific issues. Recent analyst commentary slashing price targets and questioning the turnaround timeline, as noted in news, reflects growing skepticism about Nike's near-term prospects.
Worst-Case Scenario involves a failed turnaround where new leadership cannot stem market share losses or margin erosion, leading to consecutive earnings misses and dividend cuts. In this adverse scenario, the stock could retest and break below its 52-week low of $40.0, potentially falling to levels implied by a deeper valuation reset to a P/E in the mid-teens. From the current price of $40.75, a realistic downside could be -20% to -30%, targeting a range of $28.50 to $32.60, based on historical max drawdowns nearing -50% and the absence of a clear near-term catalyst.
FAQ
The key risks are, in order of severity: 1) Operational: Continued revenue stagnation and margin erosion, as seen in the 34% sequential net income drop and 40.16% gross margin. 2) Competitive: Intense pressure from rivals like Lululemon and Deckers' Hoka, potentially leading to permanent market share loss. 3) Valuation: A premium forward P/E of 22.61x that could compress further if growth doesn't materialize. 4) Execution: The risk that new leadership fails to execute the much-anticipated turnaround, prolonging the period of weak performance.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees a range of $45-$55, assuming a slow, messy turnaround with low-single-digit growth. The Bull Case (25% probability) targets $55-$65 on a successful operational recovery. The Bear Case (20% probability) warns of a drop to $32-$40 if fundamentals worsen. The Base Case is most likely, hinging on the assumption that Nike's strong brand and finances prevent a collapse but are insufficient to drive a rapid re-rating without clear growth catalysts.
NKE is fairly valued relative to its current challenged prospects but arguably overvalued relative to its growth trajectory. The forward P/E of 22.61x implies the market still expects an earnings recovery, yet revenue growth is near zero at 0.09% YoY. Compared to its own historical trailing P/E of 27.92x, multiple compression has occurred, but the current multiple still demands successful execution of a turnaround that is not yet evident. The valuation suggests the market is paying a premium for hope, not current performance.
NKE is a Hold, not a clear Buy at current levels. For investors seeking a turnaround story with a margin of safety, the 34.84% price decline over the past year and strong financials (24.36% ROE, $2.48B FCF) are appealing. However, the stagnant 0.09% revenue growth and elevated forward P/E of 22.61x create significant risk. It could be a good buy for very patient, long-term investors who believe in the brand's ultimate recovery, but not for those seeking near-term growth or unable to withstand further volatility.
NKE is suitable only for long-term investment with a minimum horizon of 2-3 years. The stock's high beta of 1.116 and severe underperformance (-35% vs. S&P 500 over 3 months) make it far too volatile for short-term trading. The investment thesis is predicated on a multi-quarter turnaround story playing out. The 2.56% dividend provides some income while waiting, but the lack of near-term earnings visibility and clear catalysts means investors must be prepared to hold through potential further volatility before any recovery materializes.